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SERUM PHOSPHATE AS A MARKER OF CAROTID INTIMAL MEDIAL 
THICKNESS IN NON-DIABETIC CHRONIC KIDNEY DISEASE PATIENTS 
 
Background : 
Chronic Kidney disease is a significant predictor of cardiovascular mortality. 
Accelerated atherosclerosis is common in CKD patients and hence more prone for 
cardiovascular disease(CVD) mortality. Carotid intimal medial thickness (CIMT) is a 
direct marker of atherosclerosis which can be measured non-invasively using B mode 
ultrasonography to detect early atherosclerosis. 
 
Objectives : 
To study the relation between serum phosphate and carotid artery intimal 
medial thickness in non-diabetic chronic kidney disease patients and also relationship  
between other factors such as age, gender, stage of CKD, serum albumin, serum 
calcium, serum phosphate, haemoglobin, LDL cholesterol, urine protein creatinine 
ratio, calcium phosphate product, fundus and echocardiographic findings with CIMT. 
 
Methods : 
100 non-diabetic CKD patients were subjected to relevant blood investigations, 
fundus examination, echocardiography and carotid artery doppler and relationship 
between CIMT and each investigation studied separately. 
 
Results : 
In our study we found that serum phosphate and CIMT increased progressively 
with CKD progression and had an independent positive correlation with CIMT. 
Positive correlation was also observed for factors such as age, ESR, severity of LV 
dysfunction and retinopathy, urine PCR and LDL cholesterol. Negative correlation 
was observed for albumin, haemoglobin and serum calcium. 
 
Conclusion : 
Hyperphosphatemia acts as a significant risk factor for accelerated 
atherosclerosis by inducing vascular smooth muscle cell proliferation thereby leading 
to increased intimal medial thickness. Therapy aimed at reduction of serum phosphate 
levels in CKD patients by means of phosphate binders along with treatment of other 
risk factors can attenuate vascular calcification thereby reducing progression of 
atherosclerosis and incidence of vascular events. 
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